SJR 29

  • California Senate Joint Resolution
  • 2015-2016 Regular Session
  • Introduced in Senate Aug 29, 2016
  • Passed Senate Aug 30, 2016
  • Passed Assembly Aug 31, 2016
  • Governor

Relative to EpiPen.

Bill Subjects

Epipen: Pricing.


This measure would urge the United States Food and Drug Administration to reconsider its denial of approval for generic alternatives to the epinephrine auto-injector EpiPen, would urge the Congress of the United States to investigate the impact that Mylan NV's monopoly has had on price increases for EpiPen, and would urge the Congress and the President of the United States to take action to limit the unrestrained ability of drug manufacturers to increase prices based on what the market can bear.

Bill Sponsors (3)



Sep 09, 2016

California State Legislature

Enrolled and filed with the Secretary of State at 11 a.m.

California State Legislature

Chaptered by Secretary of State. Res. Chapter 191, Statutes of 2016.

Aug 31, 2016


From committee: Be adopted. Ordered to third reading. (Ayes 14. Noes 0.) (August 31).


Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.


Assembly Rule 63 suspended.


Read. Adopted. (Ayes 60. Noes 0. Page 6546.) Ordered to the Senate.


In Senate. Ordered to engrossing and enrolling.

Aug 30, 2016


In Assembly. Held at Desk.


Read. Adopted. (Ayes 39. Noes 0. Page 5528.) Ordered to the Assembly.


From committee: Ordered to third reading.

Aug 29, 2016


Introduced. Referred to Com. on RLS.

  • Introduction
  • Referral-Committee
Com. on RLS.

Bill Text

Bill Text Versions Format
08/29/16 - Introduced PDF
09/06/16 - Enrolled PDF
09/09/16 - Chaptered PDF

Related Documents

Document Format
No related documents.


Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.